NCT04014647 (MOBOS) is a clinical trial in Vascular Surgical Procedure, sponsored by Julie Dawson.

Who is sponsoring NCT04014647?

NCT04014647 is sponsored by Julie Dawson.

What condition does NCT04014647 study?

NCT04014647 studies Vascular Surgical Procedure.

Is NCT04014647 still recruiting?

NCT04014647 is currently suspended. Last updated 22 December 2023.

Last reviewed 2023-12-22 · How we verify

NCT04014647: MOBOS

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Measurement Of NT-proBNP to Predict Outcomes in Surgery

Suspended Last updated 22 December 2023

What this trial tests

trial in Vascular Surgical Procedure in 200 participants. Suspended.

Timeline

5 September 2019

Primary endpoint
1 September 2025

1 September 2025

Quick facts

Lead sponsor	Julie Dawson
Status	Suspended
Study type	OBSERVATIONAL
Enrollment	200
Start date	5 September 2019
Primary completion	1 September 2025
Estimated completion	1 September 2025
Sites	1 location across United Kingdom

Conditions studied

Vascular Surgical Procedure — all drugs for Vascular Surgical Procedure →

Sponsor

Julie Dawson — full company profile →

Who can join

18 and older, any sex, with Vascular Surgical Procedure. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The team is investigating whether N-terminal pro B-type natriuretic peptide (NT-proBNP) and other cardiac markers are useful for predicting outcomes for patients undergoing vascular surgery. By measuring NT-proBNP before and after surgery, the investigators may be able to determine which patients are at risk of an adverse outcome, such as a heart attack or death.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Vascular Surgical Procedure

Currently open trials in the same condition.

NCT07164040 — Leica Microsystems Sponsored Study to Collect and Confirm Clinical Data on the Performance of the GLOW800 Device When Us · recruiting
NCT04894864 — Opioid Free Anesthesia-Analgesia Strategy and Surgical Stress in Elective Open Abdominal Aortic Aneurysm Repair · Phase 4 · recruiting

Other Julie Dawson trials

Trials by the same sponsor.

NCT04142905 — Is Asthma in Subjects With Obstructive Sleep Apnoea (OSA) Due to Dysanapsis · unknown
NCT04156763 — Virtual Reality Test of Strabismus · terminated
NCT04031131 — The Use of Topical Anaesthetic in the Banding of Internal Haemorrhoids · Phase 2 · completed
NCT04026516 — CAVA: Dizziness Trial · NA · suspended
NCT04012515 — CAVA: Electrode Pad Appraisal Trial · NA · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04014647 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Julie Dawson
Last refreshed: 22 December 2023

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04014647.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing